Matches in Wikidata for { <http://www.wikidata.org/entity/Q58006083> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q58006083 description "article scientifique publié en 2011" @default.
- Q58006083 description "im April 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58006083 description "wetenschappelijk artikel" @default.
- Q58006083 description "наукова стаття, опублікована у квітні 2011" @default.
- Q58006083 name "A CROSS OVER STUDY, BENEFICIAL EFFECT OF INTRACORONARY NICORANDIL, A HYBRID K-ATP CHANNEL OPENER AND NITRIC OXIDE DONOR, ON MICROVASCULAR DYSFUNCTION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: DEMONSTRATION OF ITS SUPERIORITY TO INT" @default.
- Q58006083 name "A CROSS OVER STUDY, BENEFICIAL EFFECT OF INTRACORONARY NICORANDIL, A HYBRID K-ATP CHANNEL OPENER AND NITRIC OXIDE DONOR, ON MICROVASCULAR DYSFUNCTION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: DEMONSTRATION OF ITS SUPERIORITY TO INT" @default.
- Q58006083 type Item @default.
- Q58006083 label "A CROSS OVER STUDY, BENEFICIAL EFFECT OF INTRACORONARY NICORANDIL, A HYBRID K-ATP CHANNEL OPENER AND NITRIC OXIDE DONOR, ON MICROVASCULAR DYSFUNCTION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: DEMONSTRATION OF ITS SUPERIORITY TO INT" @default.
- Q58006083 label "A CROSS OVER STUDY, BENEFICIAL EFFECT OF INTRACORONARY NICORANDIL, A HYBRID K-ATP CHANNEL OPENER AND NITRIC OXIDE DONOR, ON MICROVASCULAR DYSFUNCTION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: DEMONSTRATION OF ITS SUPERIORITY TO INT" @default.
- Q58006083 prefLabel "A CROSS OVER STUDY, BENEFICIAL EFFECT OF INTRACORONARY NICORANDIL, A HYBRID K-ATP CHANNEL OPENER AND NITRIC OXIDE DONOR, ON MICROVASCULAR DYSFUNCTION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: DEMONSTRATION OF ITS SUPERIORITY TO INT" @default.
- Q58006083 prefLabel "A CROSS OVER STUDY, BENEFICIAL EFFECT OF INTRACORONARY NICORANDIL, A HYBRID K-ATP CHANNEL OPENER AND NITRIC OXIDE DONOR, ON MICROVASCULAR DYSFUNCTION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: DEMONSTRATION OF ITS SUPERIORITY TO INT" @default.
- Q58006083 P1433 Q58006083-29648D84-9019-475E-88D0-2DA8C3EB4DF5 @default.
- Q58006083 P1476 Q58006083-92028EE7-9A4B-4117-A5BC-3A4A1C9165F7 @default.
- Q58006083 P2093 Q58006083-1BE95505-8639-44B9-BA25-8C8C390ED64E @default.
- Q58006083 P2093 Q58006083-258E61FB-84DC-4D5A-A8B4-CA96B0AB1BD7 @default.
- Q58006083 P2093 Q58006083-26772EC2-5005-48F1-B43E-ECDD9DAB07DE @default.
- Q58006083 P2093 Q58006083-2906D0DC-CC46-43ED-9244-53A99640E026 @default.
- Q58006083 P2093 Q58006083-2AA3013B-8824-48A0-8954-0CC2FA531661 @default.
- Q58006083 P2093 Q58006083-412B4284-352F-4B57-9357-A9B76D21FC2E @default.
- Q58006083 P2093 Q58006083-8F3203B3-4971-4EB1-9A36-7B9CB7592A3D @default.
- Q58006083 P2093 Q58006083-92A6588F-F778-4957-BB67-C16B53AFCFB6 @default.
- Q58006083 P2093 Q58006083-9B11B421-B1FF-4066-8BBC-53B99E49E4A3 @default.
- Q58006083 P2093 Q58006083-AB2BD976-ABB8-494E-90E3-C03FE5C39B88 @default.
- Q58006083 P2093 Q58006083-C050D47D-29B3-482E-8BD0-1740DDD495C1 @default.
- Q58006083 P2093 Q58006083-D19FAFFE-FFCB-4589-8A5A-7A39EFA50F08 @default.
- Q58006083 P2093 Q58006083-D95B5C44-D5BD-42BB-9E6E-AB94D50BBCB3 @default.
- Q58006083 P2093 Q58006083-EEA0D72D-D35D-4A60-A181-A069B3EA4568 @default.
- Q58006083 P2093 Q58006083-F58338CD-02D8-4391-B2C3-B7C8DD7F7395 @default.
- Q58006083 P2093 Q58006083-FF9ADAEB-D9C3-4C03-A9EC-B4301B7D6D4A @default.
- Q58006083 P304 Q58006083-ED262AF5-8CC1-4EFA-8FCF-A72012B74F41 @default.
- Q58006083 P31 Q58006083-4CBC90F1-987E-49CE-8AFE-1DF78C57AE11 @default.
- Q58006083 P356 Q58006083-817C68E8-1465-4989-917F-AA0D5A2D4EB8 @default.
- Q58006083 P407 Q58006083-D86A531D-F74E-4B62-9B9E-1BFB6DD901E1 @default.
- Q58006083 P433 Q58006083-A374F439-957A-4FA5-99B0-F65974782040 @default.
- Q58006083 P478 Q58006083-119F3EA5-1A5A-490F-91EA-8A7219D46686 @default.
- Q58006083 P577 Q58006083-9803F195-3403-400C-89E5-9A7DA4837E0A @default.
- Q58006083 P356 S0735-1097(11)61790-7 @default.
- Q58006083 P1433 Q2984355 @default.
- Q58006083 P1476 "A CROSS OVER STUDY, BENEFICIAL EFFECT OF INTRACORONARY NICORANDIL, A HYBRID K-ATP CHANNEL OPENER AND NITRIC OXIDE DONOR, ON MICROVASCULAR DYSFUNCTION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: DEMONSTRATION OF ITS SUPERIORITY TO INT" @default.
- Q58006083 P2093 "Daisaku Masuda" @default.
- Q58006083 P2093 "Daisuke Tonomura" @default.
- Q58006083 P2093 "Hirotaka Sawano" @default.
- Q58006083 P2093 "Kei Nishiyama" @default.
- Q58006083 P2093 "Ken Nagao" @default.
- Q58006083 P2093 "Ken-ichiro Okada" @default.
- Q58006083 P2093 "Noriaki Yamada" @default.
- Q58006083 P2093 "Noritoshi Ito" @default.
- Q58006083 P2093 "Shinsuke Nanto" @default.
- Q58006083 P2093 "Shizuya Yamashita" @default.
- Q58006083 P2093 "Tatsuro Kai" @default.
- Q58006083 P2093 "Tomoaki Natsukawa" @default.
- Q58006083 P2093 "Toru Hayashi" @default.
- Q58006083 P2093 "Yasuji Doi" @default.
- Q58006083 P2093 "Yasuyuki Hayashi" @default.
- Q58006083 P2093 "Yuma Kurozumi" @default.
- Q58006083 P304 "E1790" @default.
- Q58006083 P31 Q13442814 @default.
- Q58006083 P356 "10.1016/S0735-1097(11)61790-7" @default.
- Q58006083 P407 Q1860 @default.
- Q58006083 P433 "14" @default.
- Q58006083 P478 "57" @default.
- Q58006083 P577 "2011-04-01T00:00:00Z" @default.